famotidine has been researched along with Duodenal Obstruction in 1 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Duodenal Obstruction: Hindrance of the passage of luminal contents in the DUODENUM. Duodenal obstruction can be partial or complete, and caused by intrinsic or extrinsic factors. Simple obstruction is associated with diminished or stopped flow of luminal contents. Strangulating obstruction is associated with impaired blood flow to the duodenum in addition to obstructed flow of luminal contents.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Materia, A | 1 |
| Genco, A | 1 |
| Silecchia, G | 1 |
| Basso, N | 1 |
1 other study available for famotidine and Duodenal Obstruction
| Article | Year |
|---|---|
Failure of single night-time dose of H2-receptor antagonists in the treatment of duodenal ulcer patients with bulbar stenosis.
Topics: Adult; Aged; Drug Administration Schedule; Duodenal Obstruction; Duodenal Ulcer; Famotidine; Female; | 1989 |